Conmed (CNMD) EBITDA Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Conmed | 1.06 Bn | 1.02 Bn | 183.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.00 |
| Dec 31, 2025 | -342.00 |
| Sep 30, 2025 | -182.00 |
| Jun 30, 2025 | 2,321.00 |
| Mar 31, 2025 | 286.00 |
| Dec 31, 2024 | 344.00 |
| Sep 30, 2024 | 1,338.00 |
| Jun 30, 2024 | 522.00 |
| Mar 31, 2024 | 593.00 |
| Dec 31, 2023 | 620.00 |
| Sep 30, 2023 | 134.00 |
| Jun 30, 2023 | 153.00 |
| Mar 31, 2023 | -504.00 |
| Dec 31, 2022 | -884.00 |
| Sep 30, 2022 | 1,018.00 |
| Jun 30, 2022 | -6,743.00 |
| Mar 31, 2022 | 727.00 |
| Dec 31, 2021 | 1,087.00 |
| Sep 30, 2021 | 125.00 |
| Jun 30, 2021 | 626.00 |
| Mar 31, 2021 | 418.00 |
| Dec 31, 2020 | 462.00 |
| Sep 30, 2020 | 156.00 |
| Jun 30, 2020 | -2,043.00 |
| Mar 31, 2020 | 156.00 |
| Dec 31, 2019 | 874.00 |
| Sep 30, 2019 | 438.00 |
| Jun 30, 2019 | -375.00 |
| Mar 31, 2019 | -476.00 |
| Dec 31, 2018 | -457.00 |
| Sep 30, 2018 | -70.00 |
| Jun 30, 2018 | -39.00 |
| Mar 31, 2018 | 55.00 |
| Dec 31, 2017 | 1,521.00 |
| Sep 30, 2017 | -11.00 |
| Jun 30, 2017 | 109.00 |
| Mar 31, 2017 | -618.00 |
| Dec 31, 2016 | 2,101.00 |
| Sep 30, 2016 | 55.00 |
| Jun 30, 2016 | -520.00 |
| Mar 31, 2016 | -612.00 |
| Dec 31, 2015 | -329.00 |
| Sep 30, 2015 | -662.00 |
| Jun 30, 2015 | -339.00 |